Concepedia

Carlos M. Alasino

CM

Statistics

Publications

4

Citations

125

H-Index

4

Active since

2013

Affiliations

Instituto de Oncología de Rosario(Current)

National University of Rosario

Carlos M. Alasino is an author at Instituto de Oncología de Rosario specializing in cancer therapeutics, medicine, and pharmacotherapy.

Top concepts

MedicineOncologyPharmacologyBreast CancerCancer TherapyPharmacotherapyCancer ChemotherapyCancer ResearchClinical Outcomes

Publications per year

2013–2016

4

Publications

4

Safety and Therapeutic Effect of Metronomic Chemotherapy with Cyclophosphamide and Celecoxib in Advanced Breast Cancer Patients

Herman Andrés Perroud, María J. Rico, Carlos M. Alasino et al. · Future Oncology · 2013 · 52 citations

Breast Cancer Growth, Breast Oncology, Therapeutic Effect +14

Metastatic breast cancer patients treated with low-dose metronomic chemotherapy with cyclophosphamide and celecoxib: clinical outcomes and biomarkers of response

Herman Andrés Perroud, Carlos M. Alasino, María J. Rico et al. · Cancer Chemotherapy and Pharmacology · 2015 · 45 citations

Breast Oncology, Oncology, Cancer Management +10

Quality of Life in Patients with Metastatic Breast Cancer Treated with Metronomic Chemotherapy

Herman Andrés Perroud, Carlos M. Alasino, María J. Rico et al. · Future Oncology · 2016 · 17 citations · Full text

Highlights from the 1st Latin American meeting on metronomic chemotherapy and drug repositioning in oncology, 27–28 May, 2016, Rosario, Argentina

Adriana Rosé, Nicolás André, Viviana R. Rozados et al. · ecancermedicalscience · 2016 · 11 citations · Full text

1–4 of 4